American Renal Associates Holdings Revenue, Profits - ARA Annual Income Statement

Add to My Stocks
$15.88 $0.17 (1.08%) ARA stock closing price Jul 20, 2018 (Closing)

Financial statements provide us with a way to gain insights and undertake the fundamental analysis of a company. Checking American Renal Associates Holdings stock price alone is not sufficient. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. Like any other income statement, the ARA income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a YOY revenue decline of -0.62% when compared to the same period in the past. Along with American Renal Associates Holdings assets and American Renal Associates Holdings free cash flow, American Renal Associates Holdings profits as shown in profit and loss statement give key insights about the business. The net profit for 2017 is $4.85M and the 2017 revenue is $745.1M.

View revenue and profit details for latest and last 10 financial years.
show more
Fiscal year is Jan - Dec20172016201520142013
American Renal Associates Holdings Revenues or Net Sales
745.1M749.76M652.98M560.73M495.92M
Cost Of Goods Sold (COGS)482.45M452.44M390.94M329.84M288.38M
American Renal Associates Holdings Gross Profit
262.65M297.31M262.03M230.88M207.54M
Research & Development Expense-----
Selling General & Admin Expense118.56M136.64M79.33M63.02M72.1M
Income Before Depreciation Depletion Amortization144.09M160.66M182.69M167.86M135.43M
Depreciation Depletion Amortization37.63M33.86M31.84M28.52M23.7M
Non Operating Income6.7M-3.42M---33.92M
Interest Expense29.28M35.93M45.4M44.07M43.31M
American Renal Associates Holdings Pretax Income
83.87M87.45M105.45M95.26M33.42M
Provision for Income Taxes8.19M-0.75M12.37M12.85M-8.2M
MinorityInterest70.82M88.59M74.23M66.2M62.07M
Investment Gains Losses-----
Other Income-----
Income Before Extraordinaries & Disc Operations75.68M88.2M93.07M82.4M41.62M
Extraordinary Items & Discontinued Operations-----
American Renal Associates Holdings Profit/ Loss (Net Income)
4.85M-0.38M18.84M16.19M-20.44M
Average Shares used to compute Diluted EPS31.08M28.12M---
Average Shares used to compute Basic EPS31.08M28.12M---
Income Before Nonrecurring Items20.55M29.8M---
Income from Nonrecurring Items-27.97M-30.18M---
American Renal Associates Holdings Earnings Per Share Basic Net
-0.24-0.28---
American Renal Associates Holdings Earnings Per Share Diluted Net
-0.24-0.28---
EPS Diluted Before Nonrecurring Items0.610.96---
Preferred Dividends Acc Pd-----
Dividends Common-----
Dividend Per Share Common0.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.

The key things to look for in an income statement while doing American Renal Associates Holdings stock analysis are:

  • Topline: A growing topline, as seen from the American Renal Associates Holdings revenue chart, as isn't the case with American Renal Associates Holdings indicates a sagging business. One needs to compare the YoY topline or sales growth of ARA stock with its peers like ADUS stock and HNGR stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. ARA stock had a healthy bottom line growth.

The income statement is also called statement of revenue and expense. The ARA financials along with American Renal Associates Holdings historical stock prices provide a lot of details about the firm.

American Renal Associates Holdings Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
122.15
PS Ratio (price sales ratio)
0.66
Operating Margin
11
Dividend Yield
0%